Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CLSDQ
CLSDQ
· Clearside Biomedical, Inc.
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. Based on our current plans and forecasted expenses and our cash and cash equivalents, we do not believe we will be able to fund our operations for the next 12 months from the date of this filing.”View the 10-Q filed Nov 14, 2025
Market Cap
$1.30M
Shares
5.23M
Volume
—
Avg daily vol (3M)
—
All webcasts
Earnings call · FY2022 Q2
Clearside Biomedical, Inc. (CLSDQ) Q2 2022 Earnings Call
Revenue
$384,000
-50.8% YoY
Diluted EPS
-$1.95
Gross margin · derived Q4
100.0%
Net income
-$7.81M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 9, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 12, 2022 · complete as-filed document